Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Sees Large Drop in Short Interest

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 3,200 shares, a drop of 67.7% from the February 28th total of 9,900 shares. Based on an average trading volume of 3,300 shares, the short-interest ratio is currently 1.0 days.

Clinuvel Pharmaceuticals Trading Down 4.6 %

Shares of Clinuvel Pharmaceuticals stock traded down $0.35 on Friday, reaching $7.28. 454 shares of the stock were exchanged, compared to its average volume of 2,263. Clinuvel Pharmaceuticals has a 1-year low of $6.80 and a 1-year high of $11.40. The business has a fifty day moving average price of $7.44 and a two-hundred day moving average price of $8.30.

Clinuvel Pharmaceuticals Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).